BRCA1 and ovarian neoplasm: On the other hand, loss of function mutations of BRCA1, which often occur at the early stages of breast and ovarian tumors, have been associated to epithelial-to-mesenchymal transition and transcriptional reprogramming of luminal cells into basal cells [51,52,53,54].